dormakaba

Model revision following 1Q26/27 trading update

29/10/26 -"The increase in our NAV primarily reflects the upward revision to our earnings estimates following the Q1 2026/27 trading update. Stronger-than-expected sales phasing, resilient pricing and a ..."

PDF page sample
Pages
44
Language
English
Published on
29/10/26
Download
You may also be interested by these reports :
03/11/26
Geberit’s Q3 results were broadly in line, with sales up 5.2% in local currencies and EBITDA margin at 30.2%, down 40bp year-on-year. Guidance ...
30/10/26
CRH delivered a weak Q3, cutting full-year guidance as higher energy costs squeezed US margins. Adjusted EBITDA was 2.5% below expectations despite a ...
29/10/26
The increase in our NAV primarily reflects the upward revision to our earnings estimates following the Q1 2026/27 trading update. ...
28/10/26
Dormakaba delivered a reassuring Q1 2026/27 update, with 4.0% organic growth driven by +1.3% volumes and +2.7% pricing. The quarter is broadly in ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO